A detailed history of Resources Management Corp transactions in Rallybio Corp stock. As of the latest transaction made, Resources Management Corp holds 250 shares of RLYB stock, worth $332. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 250 -0.0%
Holding current value
$332
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.91 - $4.39 $473 - $1,088
248 Added 12400.0%
250 $1,000
Q4 2023

Feb 14, 2024

SELL
$1.91 - $4.39 $473 - $1,088
-248 Reduced 99.2%
2 $1,000
Q2 2023

Aug 16, 2023

SELL
$4.31 - $8.89 $861 - $1,778
-200 Reduced 44.44%
250 $1,000
Q1 2023

May 11, 2023

BUY
$4.37 - $8.75 $874 - $1,750
200 Added 80.0%
450 $44,000
Q3 2021

Nov 12, 2021

BUY
$10.83 - $23.4 $2,707 - $5,850
250 New
250 $4,000

Others Institutions Holding RLYB

About Rallybio Corp


  • Ticker RLYB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,000
  • Market Cap $42.7M
  • Description
  • Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...
More about RLYB
Track This Portfolio

Track Resources Management Corp Portfolio

Follow Resources Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Resources Management Corp with notifications on news.